SCHEMBL4839614

SCHEMBL4839614

O=C(O)Cc1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccc(Cl)c(C(F)(F)F)c3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.40
MMP8 P22894 8/20 0.38
MMP3 P08254 4/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
USP2 O75604 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
RXRG P48443 2/20 0.36
TRPA1 O75762 1/20 0.36
PTGER3 P43115 1/20 0.36
CACNA1B Q00975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839967 0.94 MMP8 (0.38) MMP8MMP3ALDH1A1NPSR1RXRA
SCHEMBL4845420 0.89 FFAR4 (0.43) MMP8MMP3ALDH1A1NPSR1RXRA
SCHEMBL4841606 0.89 FFAR4 (0.43) MMP8MMP3ALDH1A1NPSR1RXRA
SCHEMBL4837344 0.89 RORC (0.43) MMP8MMP3
SCHEMBL4837122 0.89 RORC (0.43) MMP8MMP3
SCHEMBL4845199 0.89 FFAR4 (0.44) MMP8MMP3ALDH1A1NPSR1PTGER3
SCHEMBL4841566 0.88 MMP8 (0.45) ATMMMP8MMP3ALDH1A1NPSR1
SCHEMBL4833702 0.88 MMP8 (0.40) MMP8MMP3MAPTALDH1A1NPSR1
SCHEMBL4840866 0.88 PSEN1 (0.37) ATMMMP8MMP3RXRARXRB
SCHEMBL4839633 0.87 MMP8 (0.43) MMP8MMP3ALDH1A1NPSR1PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 ATM 1808/4885MMP8 3968/4885MMP3 3739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.